Patents
Patent applications related to metaverse decreased by 12% per year on average in the pharmaceutical industry since 2020
Credit: Bert van Dijk/Getty images.
Powered by
The global pharmaceutical industry experienced a 12% decrease in annual average growth rate (AAGR) in the number of metaverse-related patent applications between 2020 and 2022. The total number of metaverse-related grants increased by an AAGR of 9% during the same period, according to GlobalData's patent analytics database.
Notably, the number of metaverse-related patent applications in the pharmaceutical industry was 175 since 2020, while 179 applications were granted.
The top five assignees by filings accounted for 40% of patent applications
Analysis of patent applications by assignee shows that Takeda Pharmaceutical filed the most metaverse patents within the pharmaceutical industry since 2020. The company filed 16 metaverse-related patents since 2020.
It was followed by Amgen (13 applications), Autolus (13 applications), Voyager Therapeutics (11 applications) and Meta Platforms (9 applications).
The top five assignees by grants accounted for 35% of successful patent grants
Analysis of patent grants by assignee shows that C. H. Boehringer Sohn was granted 14 patents related to metaverse within the pharmaceutical industry since 2020. It was followed by Meta Platforms (12 grants), Byondis (9 grants), 3B Future Holding (9 grants), and Purdue Pharma (8 grants) and Amgen (8 grants).
Patent activity was driven by the US with a 43% share of total patent publications
The largest share of metaverse-related patent publications in the pharmaceutical industry since 2020 was held by the US with 43%, followed by China (10%) and Brazil (9%).
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Patents Analytics tracks patent filings and grants from official patent offices around the world. Proprietary analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries
